Filing Details

Accession Number:
0001062993-18-002074
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-05-10 16:05:35
Reporting Period:
2018-05-08
Accepted Time:
2018-05-10 16:05:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1098880 Intelgenx Technologies Corp. IGXT Pharmaceutical Preparations (2834) 870638336
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1649546 Andre Godin 440 Des Carmantines
Laval A8 H7X 0B6
Evp And Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value 0.00001 Acquisiton 2018-05-08 15,880 $0.63 100,380 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrants Acquisiton 2018-05-08 15,380 $0.00 15,380 $0.80
Common Stock 6% Convertible Debenture Acquisiton 2018-05-08 12,500 $0.80 12,500 $0.80
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
15,380 2018-05-08 2021-06-21 No 4 P Direct
12,500 2018-05-08 2021-06-21 No 4 P Direct
Footnotes
  1. In a private placement offering, Mr. Godin acquired 2 units of $10,000 for a total of $20,000. Each Unit is comprised of (i) 7,940 common shares, (ii) a U.S. $5,000 convertible 6% Debenture Note, and (iii) 7,690 warrants to purchase common shares.